Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy

P Ricchi, R Zarrilli, A Di Palma, AM Acquaviva - British journal of cancer, 2003 - nature.com
In this review, we discuss the available experimental evidences supporting the
chemopreventive efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) on colorectal …

Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer

S Mohan, JB Epstein - Oral oncology, 2003 - Elsevier
Cyclooxygenase-2 (COX-2) is upregulated in a number of epithelial cancers, including in
upper aerodigestive tract (UADT) premalignant and malignant lesions. The purpose of this …

Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice

M Yao, S Kargman, EC Lam, CR Kelly, Y Zheng, P Luk… - Cancer research, 2003 - AACR
A large number of epidemiological studies have shown that regular use of aspirinor other
nonsteroidal anti-inflammatory drugs (NSAIDs) results in a 40–50% reduced risk of …

Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice

MA Hull, JK Booth, A Tisbury, N Scott, C Bonifer… - British journal of …, 1999 - nature.com
Summary Expression of cyclooxygenase 2 (COX-2) is believed to play an important role in
adenoma formation in murine polyposis models, and inhibition of COX-2 activity may, at …

[HTML][HTML] Cyclooxygenases in hepatocellular carcinoma

M Cervello, G Montalto - World journal of gastroenterology: WJG, 2006 - ncbi.nlm.nih.gov
Many epidemiological studies demonstrate that treatment with non-steroidal anti-
inflammatory drugs (NSAIDs) reduce the incidence and mortality of certain malignancies …

The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia

SN Agoff, TA Brentnall, DA Crispin, SL Taylor… - The American journal of …, 2000 - Elsevier
Cyclooxygenase 2 (COX-2) overexpression has been described in sporadic colonic
neoplasia, but its role in ulcerative colitis (UC) neoplastic progression remains unexplored …